CLINICAL TRIALS PROFILE FOR ATAZANAVIR SULFATE
✉ Email this page to a colleague
All Clinical Trials for ATAZANAVIR SULFATE
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT01102972 ↗ | A Simplification Study of Unboosted Reyataz With Epzicom (ASSURE) | Completed | GlaxoSmithKline | Phase 4 | 2010-04-01 | This study is designed to compare the efficacy and safety of simplifying therapy from a regimen of atazanavir (ATV) + ritonavir (RTV) + tenofovir/emtricitabine (TDF/FTC) to a regimen of ATV + abacavir sulfate/lamivudine (ABC/3TC) without RTV in virologically suppressed, HIV-1 infected, HLA-B*5701 negative subjects for 48 weeks. |
NCT01102972 ↗ | A Simplification Study of Unboosted Reyataz With Epzicom (ASSURE) | Completed | ViiV Healthcare | Phase 4 | 2010-04-01 | This study is designed to compare the efficacy and safety of simplifying therapy from a regimen of atazanavir (ATV) + ritonavir (RTV) + tenofovir/emtricitabine (TDF/FTC) to a regimen of ATV + abacavir sulfate/lamivudine (ABC/3TC) without RTV in virologically suppressed, HIV-1 infected, HLA-B*5701 negative subjects for 48 weeks. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for ATAZANAVIR SULFATE
Condition Name
Clinical Trial Locations for ATAZANAVIR SULFATE
Trials by Country
Clinical Trial Progress for ATAZANAVIR SULFATE
Clinical Trial Phase
Clinical Trial Sponsors for ATAZANAVIR SULFATE
Sponsor Name